XML 19 R9.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 4 - Common Stock
 6 Months Ended
Jun. 30, 2017
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]
4.
Common Stock.
The shareholders have authorized
100,000,000
shares of voting common shares for issuance. On
June 30, 2017,
a total of
26,747,815
shares of common stock were either issued (
22,437,176
) or reserved for conversion of convertible debt to stock (
4,310,639
).
 
On
March 10, 2016,
the Board of Directors approved the Company to enter into private placements for the sale of up to
5,000,000
shares of the Company’s common stock (Private Placement
2016
-
2
) at a price of
$.1875
per share (aggregate offering amount of
$937,500
).
 
On
September 30, 2016,
the Board of Directors approved the Company to amend the previously authorized Private Placement
2016
-
2
offer, sale, and issuance of unregistered securities. The Private Placement
2016
-
2
was amended to offer up to
10,000,000
shares of the Company’s common stock at a price of
$.1875
per share for an aggregate offering amount of
$1,875,000.
The offering is to be completed within
one
(
1
) year of the date of approval. During the
first
quarter of
2017,
the Company sold
270,000
shares of common stock at
$.1875
per share for proceeds of
$50,625.
 
On
January 3, 2017,
Stephen T. Chen, CEO, and Bernard Cohen, CFO/VP, received
145,405
shares of common stock and
19,387
shares of common stock, respectively, as payment of a
2016
stock bonus totaling
$42,500.
The stock was issued at a price of
$.2579
per share pursuant to the Board of Directors resolution of
December 20, 2016.
The shares are recognized as stock compensation expense for the period ended
June 30, 2017.
 
On
April 3, 2017,
Stephen T. Chen, CEO, and Bernard Cohen, CFO/VP, received
76,095
shares of common stock and
10,146
shares of common stock, respectively, as payment of a
Q1
2017
stock bonus totaling
$21,250.
The stock was issued at a price of
$.2464
per share. The shares are recognized as stock compensation expense for the period ended
June 30, 2017.
 
No
stock has been sold subsequent to the balance sheet date of
June 30, 2017
and through the issue date of this report.